Not exact matches
Raydiance's technology has attracted the attention
of the U.S. Food and
Drug Administration (FDA), which in July 2007 signed the company to a two - year cooperative research and development agreement that has allowed the FDA's Center for Devices and Radiological Health (CDRH) to evaluate the use,
safety and effectiveness
of Raydiance's USP laser system in a number
of areas, including the ablation
of corneal tissues in refractive surgery and corneal repair; the administration
of light therapy for treating cancer,
cardiovascular disease and diabetes; and the removal
of plaque on teeth without damaging the enamel.
A landmark 2016 Cleveland Clinic study
of widely used pain - relieving
drugs showed that celecoxib (Celebrex) was associated with comparable
cardiovascular safety and better gastrointestinal (GI) and kidney
safety when compared...
With these technologies, we are creating heart cells from skin samples
of patients with many
cardiovascular diseases, such as heart failure, to test the
safety and efficacy
of new or existing
drugs that treat or prevent the condition.
Collectively, these studies prompted the FDA to issue a
drug safety communication in March 2015 revealing that new warning labels will be added to low testosterone
drugs regarding the possible increased risk
of cardiovascular complications.
If it is proven that the
drug's manufacturers put their desire for profit ahead
of patient
safety, an Actos user who develops bladder cancer or
cardiovascular disease may be able to pursue compensation for their injuries.